Navigation Links
Pharmasset Selected to Join the NASDAQ Biotechnology Index
Date:5/12/2008

- Index Changes Scheduled to Take Effect with the Market Open on Monday,

May 19th -

PRINCETON, N.J., May 12 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS), a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections, is pleased to announce that it has been selected to join the NASDAQ Biotechnology Index effective with the market open on May 19, 2008.

The NASDAQ Biotechnology Index is the basis for the iShares NASDAQ Biotechnology Index(sm) Fund (AMEX: IBB), which seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology Index. In addition, options based on the NASDAQ Biotechnology Index and the iShares NASDAQ Biotechnology Index Fund trade on various exchanges. For more information about the NASDAQ Biotechnology Index, including eligibility criteria, visit http://www.nasdaq.com.

About Pharmasset

Pharmasset is a clinical-stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Pharmasset is currently developing three product candidates. Clevudine, for the treatment of chronic HBV infection, is e
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Pharmasset to Present at the UBS Global Life Sciences Conference on Monday, September 24th
3. Pharmasset Accesses up to $30 Million of Working Capital
4. Pharmasset to Present at Three Investor Conferences in November 2007
5. Pharmasset Appoints Michael Rogers as Chief Development Officer
6. Pharmasset Reports Fiscal Year End 2007 Financial Results
7. Pharmasset to Present at the BIO CEO & Investor Conference 2008 on Monday, February 11th
8. Pharmasset to Present at Susquehannas Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5th
9. Pharmasset to Present at Cowen & Companys Health Care Conference on Tuesday, March 18th
10. Pharmasset Appoints Herbert J. Conrad as a Director
11. Pharmasset Receives $10 Million of Working Capital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Though health care jobs continued to be ... of Labor Statistics -- the increase was far below the ... health care jobs were added in home health care and ... 6,000 jobs. Overall, the U.S. unemployment rate stayed flat at ... reported that a total of just over 36,000 job cuts ...
(Date:6/18/2013)... June 18, 2013 PathoGenetix, ... system for rapid bacterial strain typing, announced today ... the company as Vice President of Engineering. Dr. ... the company’s RESOLUTION™ Microbial Genotyping System . ... benchtop instrument, pathogen-specific assay kits, database and software, ...
(Date:6/18/2013)... On June 11, 2013 the Centers for Medicare ... memorandum concluding that FDG Position Emission Tomography (PET) is ... strategy, and the agency ended the requirement for ... was developed jointly by the ACR and WMIS as ... Evidence Development (CED) program to determine if FDG-PET scans ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 NASA ... in March that helps better monitor potentially harmful chemicals ... microAnalyzer V2.0, which was developed by Draper Laboratory ... Station. , Astronauts breathe air that is processed and ... harmful compounds in the air, even in trace amounts, ...
Breaking Biology Technology:MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 2WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 3New Monitoring System Will Better Protect NASA Astronauts on ISS 2
... to be encouraged by the numerous positive signs that biotech ... a few: , ,& bull; The coming of the Olympics ... The continued acquisition of Midwest biotech companies by Big ... Midwest products and technology, the flip side of this is ...
... Madison, Wis. - Two University of Wisconsin-Madison faculty ... and public policy to train students how to apply ... about the neurobiology of violence and aggression," says Clark ... one of two co-organizers of the new program. "Or ...
... and agricultural equipment manufacturer Gehl Co. has developed ... control boom functions using a compact, wireless remote control pendant ... platform. The hand-held pendant can be used to raise, lower, ... engine. , ,"Our goal was to add a new ...
Cached Biology Technology:Midwest biotech on a roll 2Midwest biotech on a roll 3Midwest biotech on a roll 4UW offers new program in neuroscience and public policy 2
(Date:6/17/2013)... A Kansas State University research associate has received a ... ways to prevent the spread of malaria. , Bart ... Institutes of Health,s National Research Service Award Individual Postdoctoral ... the seventh Kansas State University researcher to receive the ... currently hold such an award. , Bryant, a university ...
(Date:6/17/2013)... of mining shale gas, is widespread across Pennsylvania, covering ... research in the Annals of the New York ... biodiversity including pollution from toxic chemicals, the building of ... "Shale gas has engendered a great deal of controversy, ... effects on biological diversity and resources have scarcely been ...
(Date:6/16/2013)... group together and move around the body called ,chase ... by scientists at UCL. , Published in Nature ... that occurs when cancer cells interact with healthy cells in ... that cancer cells recruit healthy cells and use them to ... how it could be controlled to design new therapies against ...
Breaking Biology News(10 mins):NIH fellowship helps researcher fight malaria, understand mosquito immunity 2'Chase and run' cell movement mechanism explains process of metastasis 2
... arsenal against cancer: Nanoparticles that identify, target and kill ... Led by Carl Batt, the Liberty Hyde Bailey Professor ... something like a dumbbell made of gold sandwiched ... antibodies, which target a molecule found only in colorectal ...
... existence of God and the nature of religion, two ... rooted in evolutionary biology with a focus on brain ... Lionel Tiger and pioneering neuroscientist Michael McGuire elucidate perennial ... it arise? What is its source? And why does ...
... for the most common cancers could soon come from cutting-edge ... the ESMO Conference on Sarcoma and GIST, to be held ... and some of the world,s leading experts will discuss exciting ... muscle, blood vessels, deep skin tissues, nerves and the tissues ...
Cached Biology News:Like little golden assassins, 'smart' nanoparticles identify, target and kill cancer cells 2Which came first: Religion or the brain? 2Spotlight on rare tumors in hunt for new cancer treatments 2
... Captivate magnetic separator for six ... in conjunction with the Captivate ... or other magnetic particles and ... microcentrifuge tubes. Cell Biology Cell ...
Because it is manufactured at our ISO 9001–certified facilities in Eugene, Oregon, we can guarantee that FluoroPure Grade DAPI is greater than or equal to 98% pure by HPLC....
Edited by D. Patel (1994) Comprehensive data on gel electrophoresis of proteins, nucleic acids, nucleoproteins and carbohydrates....
...
Biology Products: